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Synopsis. GlucoCEST is an MRI contrast enhancement technique sensitive to the concentration of sugar in the tissue. Because of a difference
in metabolism, it is thought that tumors consume more sugar than normal tissue. However, glucose metabolism is complex and depends on
many processes, which are all important to understand the origin of the measured signal. To achieve this goal we apply here a process analysis
method to a deterministic system describing the metabolism of glucose in the tissue.
Introduction. Chemical Exchange Saturation Transfer (CEST) is an MRI contrast enhancement technique that enables the indirect detection
of molecules with exchangeable protons [1]. GlucoCEST is a CEST technique that measures a signal related to the concentration of injected
glucose and its derivates [1]. It is expected that metabolic anomalies due to the presence of cancerous tissue could be measured or characterized
by means of glucoCEST, and in particular to its dynamic characteristics. There the signal is analyzed as a function of time following glucose
metabolism, which is paramount to pathological tissue assessment. Different subvoxel compartments contribute to the signal. Particularly,
a simplified model made as a system composed by 19 Ordinary Differential Equations (ODEs) can be used in a first step, where different
parameters can be set to simulate healthy or tumor-like conditions [2]. The system accounts for the presence of vascular glucose, its equilibrium
within the interstitial environment, and the transport into the intracellular space. The purpose of this work is to identify the processes that
contribute more to the signal. This analysis allows designing a reduced model, dedicated to the fitting of experimental data, and quantification
of physiological parameters. To do so we apply Principal Process Analysis (PPA) [3, 4], a numerical method for the analysis and reduction
of biological systems designed with ODE formalism. PPA allows associating a dynamic weight to all involved processes and inferring their
importance during the acquisition time.
Methods. We consider each ODE of the system as a sum of biological processes. Let
x˙i =
∑
j
fi,j(x, p) (1)
where x = (x1, x2, . . . , xn) ∈ <n is the vector of concentrations of glucose in different compartments and p ∈ <b is the vector of parameters.
fi,j(x, p) is the j
th process involved in the dynamical evolution of the ith variable of the system over the acquisition time [0, T ]. A relative
weight Wi,j(t, p) is associated to each process fi,j(x(t), p), to study its influence in the evolution of the variable xi over time t:
Wi,j(t, p) =
|fi,j(x(t), p)|∑
j |fi,j(x(t), p)|
(2)
where 0 ≤ Wi,j(t, p) ≤ 1 and
∑
jWi,j(t, p) = 1. We use the thresholds δ and ν to detect not only the inactive processes but also to make
a further distinction between processes with a moderate activity and a fully activity. We call a process fi,j(x(t), p) inactive at time t when
Wi,j(t, p) < δ, moderately active at time t when δ ≤ Wi,j(t, p) < ν, fully active at time t when Wi,j(t, p) ≥ ν. Furthermore, because the
glucoCEST signal y is seen as a sum of the glucose concentration in different compartments (described by six variables of the model in [2]) we
also compute the contribution of each variable xi(t) for the system output y(t) =
∑
i xi(t):
Mi(t) =
xi(t)∑
i xi(t)
(3)
where 0 ≤ Mi(t) ≤ 1 and
∑
iMi(t) = 1. Their activity is dictated in the same manner by the thresholds δ and ν, set at 0.1 and 0.4. The
outcome of the analysis is summarized with an extended Boolean Process Map [3] called 3-Level Process Map with three possible activity
outcomes.
Results. Fig. 1 shows the two different CEST signals simulated in healthy and cancerous tissue after an IV bolus, using the parameters
described in [2]. The two 3-Level Process Maps in Fig. 2 reports the activity of the system variables that contribute to the CEST signal and
of their relative processes, in both healthy and cancerous tissue.
Discussion. The map in Fig. 2A shows that in a healthy tissue the highest contribution in the generation of CEST signal is given by
the glucose in the interstitial compartment as seen during an IP bolus situation [5]. Fig. 2B shows that in the tumor case the interstitial
contribution becomes inactive because the glucose carriers bring the glucose faster into the cell. For the first minutes after the injection the
vascular compartment is fully active and then it becomes moderately active because most of the glucose bolus has passed through the tissue.
From our theoretical developments, the intracellular compartment seems to be dominated by glucose and fructose-1,6-biphosphate within
healthy tissue (Fig. 2A), while glucose-6-phosphate and fructose-6-phosphate dominates in cancerous tissue (Fig. 2B).
Conclusion. We have presented the PPA of a glucose metabolism model, in the context of dynamic glucoCEST imaging. It shows that
dominant processes are different depending on the properties of the tissue. It would be interesting to apply the technique for different kind
of tumors and glucose administration. Based on this analysis we can build different reduced models where the processes that remain inactive
have been removed.
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Figure 1: CEST signal in a healthy tissue (blue color) and cancerous tissue (red color) during an acquisition time of 150 minutes.
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Figure 2: Activity of six model variables of glucoCEST model and of their processes during a 150-minute period in an healthy (A) and
cancerous tissue (B). Processes are listed in the first column (white background) ordered by variable (white background, in bold). Their
activity is depicted in the second column between 0 and 150 minutes. A horizontal dark blue (black) bar is displayed when the variable
(process) is fully active, blue (grey) when it is moderately active and light blue (white) when it is inactive.
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